SG164382A1 - Use of azithromycin for the production of a medicament for treatment of ocular infections - Google Patents

Use of azithromycin for the production of a medicament for treatment of ocular infections

Info

Publication number
SG164382A1
SG164382A1 SG201005298-3A SG2010052983A SG164382A1 SG 164382 A1 SG164382 A1 SG 164382A1 SG 2010052983 A SG2010052983 A SG 2010052983A SG 164382 A1 SG164382 A1 SG 164382A1
Authority
SG
Singapore
Prior art keywords
azithromycin
medicament
treatment
production
ocular infections
Prior art date
Application number
SG201005298-3A
Other languages
English (en)
Inventor
Luyckx Jacques
Frederic Pilotaz
Goldschmidt Pablo
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35445697&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG164382(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thea Lab filed Critical Thea Lab
Publication of SG164382A1 publication Critical patent/SG164382A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG201005298-3A 2005-04-22 2006-04-21 Use of azithromycin for the production of a medicament for treatment of ocular infections SG164382A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504069A FR2884716B1 (fr) 2005-04-22 2005-04-22 Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires

Publications (1)

Publication Number Publication Date
SG164382A1 true SG164382A1 (en) 2010-09-29

Family

ID=35445697

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201005298-3A SG164382A1 (en) 2005-04-22 2006-04-21 Use of azithromycin for the production of a medicament for treatment of ocular infections

Country Status (25)

Country Link
US (2) US20060252711A1 (ru)
EP (1) EP1877066A1 (ru)
JP (1) JP2008536908A (ru)
KR (1) KR20080008377A (ru)
CN (1) CN101163486B (ru)
AR (1) AR053591A1 (ru)
AU (1) AU2006238595A1 (ru)
BR (1) BRPI0608375A2 (ru)
CA (1) CA2603833A1 (ru)
EA (1) EA200702295A1 (ru)
FR (1) FR2884716B1 (ru)
HK (1) HK1119064A1 (ru)
IL (1) IL186092A (ru)
JO (1) JO3448B1 (ru)
MA (1) MA29467B1 (ru)
MX (1) MX2007013054A (ru)
MY (1) MY169533A (ru)
NO (1) NO20075943L (ru)
PE (1) PE20070157A1 (ru)
SG (1) SG164382A1 (ru)
TN (1) TNSN07370A1 (ru)
TW (1) TWI430799B (ru)
UA (1) UA94708C2 (ru)
WO (1) WO2006111844A1 (ru)
ZA (1) ZA200709872B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2098219A1 (en) 2008-03-05 2009-09-09 PARI Pharma GmbH Macrolide compositions having improved taste and stability
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
TWI572352B (zh) * 2012-03-01 2017-03-01 波麥堤克藥學Smt有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001505855A (ja) * 1996-12-09 2001-05-08 ボシュ アンド ロム インコーポレイテッド 使い捨て可撓容器
DE69825128T3 (de) * 1997-12-02 2010-05-06 Pfizer Products Inc., Groton Verwendung von azithromycin zur topischen behandlung von augeninfektionen
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
FR2823441B1 (fr) * 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation

Also Published As

Publication number Publication date
MY169533A (en) 2019-04-22
WO2006111844A1 (fr) 2006-10-26
CN101163486B (zh) 2011-11-30
AU2006238595A1 (en) 2006-10-26
NO20075943L (no) 2008-01-15
BRPI0608375A2 (pt) 2010-08-31
CA2603833A1 (fr) 2006-10-26
ZA200709872B (en) 2008-09-25
TNSN07370A1 (fr) 2009-03-17
FR2884716B1 (fr) 2009-08-21
JO3448B1 (ar) 2020-07-05
IL186092A0 (en) 2008-01-20
US20060252711A1 (en) 2006-11-09
TW200716142A (en) 2007-05-01
PE20070157A1 (es) 2007-03-09
AR053591A1 (es) 2007-05-09
EP1877066A1 (fr) 2008-01-16
US20100069315A1 (en) 2010-03-18
UA94708C2 (ru) 2011-06-10
IL186092A (en) 2016-05-31
MA29467B1 (fr) 2008-05-02
HK1119064A1 (en) 2009-02-27
CN101163486A (zh) 2008-04-16
EA200702295A1 (ru) 2008-04-28
FR2884716A1 (fr) 2006-10-27
MX2007013054A (es) 2008-01-14
TWI430799B (zh) 2014-03-21
KR20080008377A (ko) 2008-01-23
JP2008536908A (ja) 2008-09-11

Similar Documents

Publication Publication Date Title
MY147478A (en) Microbiologically stabilised beer
TW200716519A (en) Benzoyl-substituted serineamides
MX2008014101A (es) Acidos carboxilicos sustituidos con 4,5-difenil-pirimidinilamino, metodo para su produccion y su uso como medicamentos.
UY29636A1 (es) 2,4-diamino-pirimidinas como inhibidores de aurora
WO2007067559A3 (en) Antibacterial agents
UY28702A1 (es) Derivados de quinazolina
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
ATE380188T1 (de) Substituierte chinolone
ATE531703T1 (de) Benzochromenderivate
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
ATE420089T1 (de) Substituierte azachinazoline mit antiviraler wirkung
BRPI0712312A2 (pt) Composto, processo para a produção do mesmo, composição farmacêutica, agente antimicrobiano, agente anti-mrsa, método para a prevenção ou o tratamento de uma doença infecciosa, e, uso do composto
SG164382A1 (en) Use of azithromycin for the production of a medicament for treatment of ocular infections
CL2011001829A1 (es) 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo.
ATE407126T1 (de) Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on
ATE410443T1 (de) Heterocyclyl-substituierte nonadepsipeptide
UY31204A1 (es) Derivados de macrolactona
ATE524488T1 (de) Lysobactinamide
FR2905600B1 (fr) Traitement des vertiges par l'acetyl-l-leucine.
BR0311385B1 (pt) oxatinacarboxamidas, seu processo de preparação e seu emprego, agente e seu processo de preparação, bem como processo para o combate de microorganismos indesejados
DE502006008777D1 (de) Phenylen-bis-oxazolidin-derivate und ihre verwendung als antikoagulantien
ATE553088T1 (de) Substituierte chinolone ii
DK1904511T3 (da) Homogemcitabin
SE0400522D0 (sv) A medical solution, a method for producing said medical solution and use thereof
TW200615259A (en) Pesticidal agents